We are monitoring the impact of COVID-19 on Drug Delivery Devices Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2251
Share on
Share on

Global Drug Delivery Devices Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Route Of Administration, Facility of use & Region - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2251
Pages: 180

Global Drug Delivery Devices Market Size (2021 to 2026)

The size of the global drug delivery devices market is expected to reach USD 1931.2 Million by 2026. This market was worth USD 1403 Million in 2021 and growing at a CAGR of 6.66% from 2021 to 2026.

Drugs can be managed directly into the body through infusions, imbuement, or others. Drug delivery technologies are the formulations or devices used to infuse restorative substances in the body through a particular course of the organization. Different drug formulations, for example, insulin and anti-infection agents, are managed through drug delivery devices. These devices help expand the effectiveness of Drug delivery by controlling the time, measurement, and place of arrival of the drugs in the body.

MARKET DRIVERS:

The rise in the incidences of various health disorders due to changes in the lifestyle and food habits in this modern generation is undoubtedly a primary factor propelling the demand for the drug delivery devices market. The growing prevalence of maintaining good health after taking specific treatment procedures like surgeries and chemotherapy is accelerating the market demand. The need to have accurate dosage levels in a scheduled time period and increasing awareness over the availability of different treatment procedures across the world are further driving the growth of the drug delivery devices market.

Increasing support from the government by launching reimbursement schemes is solely to set up growth opportunities for the market. The rise in the research institutes in the medical sector to launch innovative products favoring the end-user is lavishing the market's demand. Growing priority for biocompatible devices is significantly influencing the growth of the market.

MARKET RESTRAINTS:

However, the lack of standardization is slowly hampering the demand of the market. Lack of knowledge over utilizing these devices, especially in rural areas, limits the market's growth. Some of these devices manufactured with advanced technology are a bit expensive, and this factor is challenging the market developers.

Impact of COVID-19 on the global drug delivery devices market:

The continuous COVID-19 widespread is positioned to force the global drug delivery devices market to increase at a prominent CAGR during the forecast period. Many hospitals, clinics, and other healthcare organizations are affected by COVID-19 in forwarding their resources in fighting the disease. Manufacturing of respirators like oxygen masks, ventilators, and inhalers, nebulizers have surged the protection of patients affected with the virus. The analysis is still happening in different drug delivery systems in preventing the growth of the virus developed within the human body. For example, Pfizer, Inc. is developing a COVID-19 mRNA vaccine program titled BNT162 and now in the PHASE III clinical trial. Novartis AG proposes to examine the canakinumab monoclonal antibody among the patients. Many other vaccine clinical trials for the enhancement of novel drugs and drug delivery systems are under process.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Route of Administration, Facility of Use, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

 

This research report on the global drug delivery devices market has been segmented and sub-segmented based on the route of administration, facility of use, and region.

Drug Delivery Devices Market – By Route of administration:

  • Oral Drug Delivery
  • Pulmonary Drug Delivery
  • Injectable Drug Delivery
  • Ocular Drug Delivery
  • Nasal Drug Delivery
  • Topical Drug Delivery
  • Implantable Drug Delivery
  • Tran mucosal Drug Delivery

Based on the administration route, the Oral drug delivery segment leads with the highest shares of the market. The increasing geriatric population is one of the factors spurring the demand of the market. Rising expenditure on healthcare is gradually leveling up the growth of the market.

Drug Delivery Devices Market – By Facility of Use:

  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Diagnostic Centers
  • Others

Based on the Facility of Use, the Hospitals sector is having dominant shares of the market. Increasing funds from private and public organizations to construct hospitals with the latest equipment is lavishing the market's growth.

Drug Delivery Devices Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, North America is accounted for in leading the highest shares of the global drug delivery devices market by owing to the quick adoption of the latest technological developments. The Asia Pacific and Europe are following North America in holding significant shares of the market with the rising economy in almost every country. Also, changes in government schemes in favor of the public is elevating the demand of the market. The Middle East and Africa are anticipated to have substantial growth opportunities in the coming years.

KEY MARKET PARTICIPANTS:

Companies that are playing a dominating role in the global drug delivery devices market profiled in this report are Bend Research, Endocyte, Microchips Inc., Pearl Therapeutics Inc., Presage Bioscience, UCB Group, Genentech Inc., Polymer Factory, Alkermes Inc., BIND Biosciences Inc., and QLT Inc.

RECENT MARKET HAPPENINGS:

  • On November 17, 2020, UCB Group made a public statement that it got approval from U.S FDA for its VIMPAT CV secondary therapy to treat primarily generalized tonic-clonic seizures among patients of age four and older.
  • On June 29, 2020, Genentech Inc. received FDA approval for breast cancer treatment drugs those alliances Herceptin and Perjeta. Genentech has united two monoclonal antibodies, administered by a single injection and intravenous chemotherapy.
  • On November 15, 2019, BIOCORP made a contract agreement with VITROBIO PHARMA to manufacture the first drug for the treatment against allergy to pollution. The researchers took around 20 years to manufacture an effective drug for respiratory distress syndrome.
  • On May 26, 2020, Propeller Health won FDA clearance for making their patients use Symbicort inhaler. In particular, this inhaler to be used by asthma and Chronic Obstructive Pulmonary Disease (COPD) patients.
  • On January 29, 2020, Aptar and Lupin have introduced a smart inhaler device for breathing problems. The device is for metered-dose inhalers (MDI), known as ADHERO, and is used to help patients suffering from chronic respiratory diseases.
  • On September 14, 2020, Accord Healthcare agreed with Molteni Pharmaceutical for the commercialization of Sixmo. This Sixmo is an opioid against therapy treatment. Delivered over first of its kind implant.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Route of administration                        

                                5.1.1 Introduction           

                                5.1.2 Oral Drug Delivery

                                5.1.3 Pulmonary Drug Delivery  

                                5.1.4 Inject able Drug Delivery   

                                5.1.5 Ocular Drug Delivery           

                                5.1.6 Nasal Drug Delivery             

                                5.1.7 Topical Drug Delivery          

                                5.1.8 Implantable Drug Delivery                

                                5.1.9 Tran mucosal Drug Delivery             

                                5.1.10  Y-o-Y Growth Analysis, By Route of administration            

                                5.1.11  Market Attractiveness Analysis, By Route of administration          

                                5.1.12  Market Share Analysis, By Route of administration            

                5.2 Facility of use                             

                                5.2.1 Introduction           

                                5.2.2 Hospitals  

                                5.2.3 Ambulatory Surgical Centers           

                                5.2.4 Home care settings             

                                5.2.5 Diagnostic Centers               

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Facility of use    

                                5.2.8 Market Attractiveness Analysis, By Facility of use  

                                5.2.9 Market Share Analysis, By Facility of use    

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 Route of administration

                                                6.1.3.3 By Facility of use

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Route of administration

                                                6.1.4.3 By Facility of use

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Route of administration

                                                6.1.5.3 By Facility of use

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Bend Research                          

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Endocyte                     

                8.3 MicroCHIPS Inc                         

                8.4 Pearl Therapeutics Inc                           

                8.5 Presage Bioscience                 

                8.6 UCB Group                 

                8.7 Genentech Inc                          

                8.8 Polymer Factory                       

                8.9 Alkermes Inc                              

                8.10 BIND Biosciences Inc                            

                8.11 QLT Inc                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organisations a strong financial foothold in the market
  1. Global Drug Delivery Devices Market, By Region, From 2021 to 2026 (USD Million)
  2. Global Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  3. Global Oral Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  4. Global Pulmonary Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  5. Global Injectable Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  6. Global Ocular Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  7. Global Nasal Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  8. Global Topical Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  9. Global Implantable Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  10. Global Tran mucosal Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  11. Global Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  12. Global Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  13. Global Ambulatory Surgical Centers Market, By Region, From 2021 to 2026 (USD Million)
  14. Global Home Care settings Market, By Region, From 2021 to 2026 (USD Million)
  15. Global Diagnostic Centers Market, By Region, From 2021 to 2026 (USD Million)
  16. Global Others Market, By Region, From 2021 to 2026 (USD Million)
  17. North America Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  18. North America Oral Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  19. North America Pulmonary Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  20. North America Injectable Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  21. North America Ocular Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  22. North America Nasal Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  23. North America Topical Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  24. North America Implantable Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  25. North America Tran mucosal Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  26. North America Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  27. North America Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  28. North America Ambulatory Surgical Centers Market, By Region, From 2021 to 2026 (USD Million)
  29. North America Home Care settings Market, By Region, From 2021 to 2026 (USD Million)
  30. North America Diagnostic Centers Market, By Region, From 2021 to 2026 (USD Million)
  31. North America Others Market, By Region, From 2021 to 2026 (USD Million)
  32. United States Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  33. United States Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  34. Canada Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  35. Canada Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  36. Europe Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  37. Europe Oral Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  38. Europe Pulmonary Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  39. Europe Injectable Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  40. Europe Ocular Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  41. Europe Nasal Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  42. Europe Topical Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  43. Europe Implantable Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  44. Europe Tran mucosal Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  45. Europe Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  46. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  47. Europe Ambulatory Surgical Centers Market, By Region, From 2021 to 2026 (USD Million)
  48. Europe Home Care settings Market, By Region, From 2021 to 2026 (USD Million)
  49. Europe Diagnostic Centers Market, By Region, From 2021 to 2026 (USD Million)
  50. Europe Others Market, By Region, From 2021 to 2026 (USD Million)
  51. U.K. Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  52. U.K. Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  53. Germany Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  54. Germany Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  55. France Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  56. France Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  57. Italy Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  58. Italy Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  59. Spain Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  60. Spain Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  61. Asia-Pacific Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  62. Asia-Pacific Oral Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  63. Asia-Pacific Pulmonary Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  64. Asia-Pacific Injectable Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  65. Asia-Pacific Ocular Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  66. Asia-Pacific Nasal Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  67. Asia-Pacific Topical Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  68. Asia-Pacific Implantable Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  69. Asia-Pacific Tran mucosal Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  70. Asia-Pacific Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  71. Asia-Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  72. Asia-Pacific Ambulatory Surgical Centers Market, By Region, From 2021 to 2026 (USD Million)
  73. Asia-Pacific Home Care settings Market, By Region, From 2021 to 2026 (USD Million)
  74. Asia-Pacific Diagnostic Centers Market, By Region, From 2021 to 2026 (USD Million)
  75. Asia-Pacific Others Market, By Region, From 2021 to 2026 (USD Million)
  76. Japan Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  77. Japan Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  78. China Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  79. China Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  80. India Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  81. India Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  82. Australia Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  83. Australia Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  84. South Korea Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  85. South Korea Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  86. Latin America Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  87. Latin America Oral Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  88. Latin America Pulmonary Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  89. Latin America Injectable Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  90. Latin America Ocular Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  91. Latin America Nasal Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  92. Latin America Topical Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  93. Latin America Implantable Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  94. Latin America Tran mucosal Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  95. Latin America Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  96. Latin America Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  97. Latin America Ambulatory Surgical Centers Market, By Region, From 2021 to 2026 (USD Million)
  98. Latin America Home Care settings Market, By Region, From 2021 to 2026 (USD Million)
  99. Latin America Diagnostic Centers Market, By Region, From 2021 to 2026 (USD Million)
  100. Latin America Others Market, By Region, From 2021 to 2026 (USD Million)
  101. Brazil Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  102. Brazil Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  103. Argentina Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  104. Argentina Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  105. Mexico Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  106. Mexico Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  107. Rest of Latin America Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  108. Rest of Latin America Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  109. Middle East & Africa Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  110. Middle East & Africa Oral Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  111. Middle East & Africa Pulmonary Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  112. Middle East & Africa Injectable Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  113. Middle East & Africa Ocular Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  114. Middle East & Africa Nasal Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  115. Middle East & Africa Topical Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  116. Middle East & Africa Implantable Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  117. Middle East & Africa Tran mucosal Drug Delivery Market, By Region, From 2021 to 2026 (USD Million)
  118. Middle East & Africa Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  119. Middle East & Africa Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  120. Middle East & Africa Ambulatory Surgical Centers Market, By Region, From 2021 to 2026 (USD Million)
  121. Middle East & Africa Home Care settings Market, By Region, From 2021 to 2026 (USD Million)
  122. Middle East & Africa Diagnostic Centers Market, By Region, From 2021 to 2026 (USD Million)
  123. Middle East & Africa Others Market, By Region, From 2021 to 2026 (USD Million)
  124. Middle East Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  125. Middle East Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)
  126. Africa Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Million)
  127. Africa Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample